Australia revises guide on microbial resistance risk data requirements
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration has proposed revisions to its guideline on the antimicrobial resistance risk data that antibacterial medicinal product makers should submit in their marketing applications to the agency1,2.